Human Metabolome Technologies (TSE:6090) Inventories, Finished Goods: 円19.7 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:6090 Human Metabolome Technologies Inc TSE:6090
59 GF Score
Price 円591.00
GF Value 円531.46
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Human Metabolome Technologies Inventories, Finished Goods?

Human Metabolome Technologies TSE:6090 -1.34% 59 Inventories, Finished Goods is 円19.7 Mil as of Dec. 2025. GuruFocus rates TSE:6090 with a GF Score™ of 59/100 and a GF Value™ of 円531.46 (Modestly Overvalued). The stock has 4 warning signs investors should review.

Human Metabolome Technologies's quarterly finished goods increased from Jun. 2025 (円18.1 Mil) to Sep. 2025 (円22.6 Mil) but then declined from Sep. 2025 (円22.6 Mil) to Dec. 2025 (円19.7 Mil).

Human Metabolome Technologies's annual finished goods declined from Jun. 2022 (円18.9 Mil) to Jun. 2023 (円11.2 Mil) and declined from Jun. 2023 (円11.2 Mil) to Jun. 2024 (円11.1 Mil).


Human Metabolome Technologies Inventories, Finished Goods Historical Data

* Premium members only.

The historical data trend for Human Metabolome Technologies's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Human Metabolome Technologies Inventories, Finished Goods Chart

Human Metabolome Technologies Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Jun20 Jun21 Jun22 Jun23 Jun24
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 26.11 21.85 18.86 11.22 11.12

Human Metabolome Technologies Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.74 18.14 22.64 19.72 13.18
TSE:6090
59GF Score
Human Metabolome Technologies Inc TSE:6090
Inventories, Finished Goods is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Human Metabolome Technologies Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

What does a Inventories, Finished Goods of 円19.7 Mil mean?
Human Metabolome Technologies (TSE:6090) has a Inventories, Finished Goods of 円19.7 Mil as of Dec. 2025. Finished goods are inventory items that are complete and ready to be sold. View historical data on Human Metabolome Technologies and its competitors.
Is Human Metabolome Technologies' Inventories, Finished Goods too high?
Human Metabolome Technologies' current Inventories, Finished Goods is 円19.7 Mil. Overall, Human Metabolome Technologies has a GF Score™ of 59/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Human Metabolome Technologies' Inventories, Finished Goods compare to TMO and DHR?
Human Metabolome Technologies' Inventories, Finished Goods of 円19.7 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Medical Diagnostics & Research company?
A good Inventories, Finished Goods depends on the Medical Diagnostics & Research industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on Human Metabolome Technologies and its competitors. Human Metabolome Technologies's current Inventories, Finished Goods is 円19.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Human Metabolome Technologies stock overvalued right now?
Based on GuruFocus' analysis, Human Metabolome Technologies (TSE:6090) is currently considered Modestly Overvalued. The stock's GF Value™ is 円531.46, compared to a current price of 円591.00 — trading 11.2% above its estimated fair value. The current Inventories, Finished Goods is 円19.7 Mil. Human Metabolome Technologies' overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For Human Metabolome Technologies (TSE:6090), the current Inventories, Finished Goods is 円19.7 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Human Metabolome Technologies (TSE:6090) Overvalued in 2026?

Based on GuruFocus' analysis, Human Metabolome Technologies stock appears to be overvalued. The current stock price of 円591.00 is trading 11.2% above its estimated GF Value™ of 円531.46. GuruFocus considers Human Metabolome Technologies to be Modestly Overvalued.

Key valuation signals for TSE:6090:

  • Inventories, Finished Goods: 円19.7 Mil
  • GF Value™: 円531.46 vs. price of 円591.00 (11.2% above fair value)
  • GF Score™: 59/100 with 4 warning signs

No single metric tells the full story. See the TSE:6090 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Human Metabolome Technologies Business Description

Address Yamagata Prefecture Kakuganji Water 246-2, Tsuruoka, JPN, 997-0052
Human Metabolome Technologies Inc is involved in the search and diagnosis of biomarkers and commercialization in the field of drug development.
59GF Score

Get the complete analysis for TSE:6090

Inventories, Finished Goods is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円591.00
Price
円531.46
GF Value